Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC) Meeting Abstract
| Authors: | Sherman, E. J.; Tsai, C. J.; Zhi, W. I.; Fetten, J. V.; Wu, V.; Ho, A. L.; Riaz, N.; Pfister, D. G.; Lee, N. Y. |
| Abstract Title: | Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 363s |
| Language: | English |
| ACCESSION: | WOS:000487345806053 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.6088 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6088 -- Source: Wos |
